08.19.2020 - By Psychopharmacology Institute
We discuss a study on the use of the mu-opioid receptor antagonist, samidorphan for olanzapine-induced weight gain, compared to placebo and naltrexone. Earn 0.5 CME here Become a premium member of the Psychopharmacology Institute